Kepos Capital LP Merck & Co., Inc. Transaction History

Kepos Capital LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$113.24 - $131.95 $32,046 - $37,341	283 New	283 $37,000
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $28,330 - $36,323	324 New	324 $36,000
Q1 2020 May 12, 2020	SELL	$63.36 - $87.82 $278,784 - $386,407	-4,400 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $341,352 - $385,176	4,400 New	4,400 $400,000
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $2.28 Million - $2.48 Million	-29,926 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $3 Million - $3.51 Million	-42,987 Reduced 58.96%	29,926 $2.51 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $212,149 - $241,968	3,049 Added 4.36%	72,913 $6.06 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $4.56 Million - $5.29 Million	69,864 New	69,864 $5.34 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $912,828 - $1.07 Million	-15,823 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $804,283 - $944,949	15,823 New	15,823 $960,000
Q4 2017 Feb 12, 2018	SELL	$51.62 - $61.64 $276,476 - $330,143	-5,356 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $314,236 - $338,124	5,356	5,356 $343,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.